title: Current update on primary and secondary sclerosing cholangitis.
abstract: Sclerosing cholangitis can be idiopathic (primary) or secondary to an identifiable cause. Irrespective of cause, sclerosing cholangitis usually progresses to end-stage liver disease and warrants orthotopic liver transplantation. Recent studies provide new insights into the etiopathogenesis, natural history, diagnosis, and management of these different entities.
authors.affiliation: Department of Radiology, University of Texas Health Science Center, San Antonio, USA.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Lalwani
authors.forename: Puneet
authors.initials: P
authors.lastname: Bhargava
authors.forename: Kedar N
authors.initials: KN
authors.lastname: Chintapalli
authors.forename: Alampady
authors.initials: A
authors.lastname: Shanbhogue
authors.forename: Arpit M
authors.initials: AM
authors.lastname: Nagar
authors.forename: Srinivasa R
authors.initials: SR
authors.lastname: Prasad
mesh_terms: D000328:Adult; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D058625:End Stage Liver Disease / Q000175:diagnosis* / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D016031:Liver Transplantation; D008875:Middle Aged; D012680:Sensitivity and Specificity; D014481:United States / Q000453:epidemiology; D055815:Young Adult